Published 3 years ago

Plasma from recovered patients shows little benefit in those hospitalized with COVID-19

Summary by Reuters

Using blood plasma from COVID-19 survivors to treat patients with severe pneumonia caused by the novel coronavirus showed little benefit, according to data released on Tuesday from a clinical trial in Argentina. The therapy know as convalescent plasma, which delivers antibodies from COVID-19 survivors to infected people, did not significantly improve patients'

0 Articles

All

Left

Center

Right

Yahoo News

Plasma from recovered patients shows little benefit in those hospitalized with COVID-19

3 years ago·Los Angeles, United States

Read Full Article

Reuters

Plasma from recovered patients shows little benefit in those hospitalized with COVID-19

By Vishwadha Chander - Using blood plasma from COVID-19 survivors to treat patients with severe pneumonia caused by the novel coronavirus showed little benefit, according to data released on Tuesday from a clinical trial in Argentina. The therapy know as convalescent plasma, which delivers antibodies from COVID-19 survivors to infected people, did not significantly improve patients'

3 years ago·United Kingdom

Read Full Article

The Star Kuala Lumpur

Plasma from recovered patients shows little benefit in those hospitalized with COVID-19

(Reuters) - Using blood plasma from COVID-19 survivors to treat patients with severe pneumonia caused by the novel coronavirus showed little benefit, according to data released on Tuesday from a clinical trial in Argentina. Read full story

3 years ago·Malaysia

Read Full Article

WION

Does plasma therapy help coronavirus patients? This study reveals shocking results

Plasma from recovered COVID-19 patients is being used across the world in hopes of treating serious cases of coronavirus. Data from a clinical trial in Argentina claims that using blood plasma of coronavirus survivors in severe cases of pneumonia triggered by the virus exhibited very little benefit.

3 years ago·Noida, India

Read Full Article

Science Media Centre

expert reaction to study looking at convalescent plasma in people with COVID-19 severe pneumonia

A paper published in NEJM looks at the clinical outcomes of patients with severe COVID-19 pneumonia treated with convalescent plasma, compared to those who received a placebo. Please note that at the time of writing this comment only the abstract of the paper was available:Prof Martin Landray, Professor of Medicine & Epidemiology, Nuffield Department of Population Health, University of Oxford, said:“There is substantial interest in convalescent …

3 years ago·London, United Kingdom

Read Full Article

researchsquare.com

A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working aga…

Background:The COVID-19 pandemic has imposed an enormous burden on health care systems around the world. In the past, the administration of convalescent plasma of patients having recovered from SARS and severe influenza to patients actively having the disease, showed pr...

3 years ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right1Center2Last Updated3 years agoBias Distribution

67% Center

Bias Distribution

67% of the sources are Center

67% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Plasma from recovered patients shows little benefit in those hospitalized with COVID-19

0 Articles

0 Articles

Plasma from recovered patients shows little benefit in those hospitalized with COVID-19

Plasma from recovered patients shows little benefit in those hospitalized with COVID-19

Plasma from recovered patients shows little benefit in those hospitalized with COVID-19

Plasma from recovered patients shows little benefit in those hospitalized with COVID-19

Plasma from recovered patients shows little benefit in those hospitalized with COVID-19

Plasma from recovered patients shows little benefit in those hospitalized with COVID-19

Does plasma therapy help coronavirus patients? This study reveals shocking results

Does plasma therapy help coronavirus patients? This study reveals shocking results

expert reaction to study looking at convalescent plasma in people with COVID-19 severe pneumonia

expert reaction to study looking at convalescent plasma in people with COVID-19 severe pneumonia

A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working aga…

A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working aga…

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics